as of Oct 23
AME
DefensiveAMETEK INC
AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. It operates through EIG and EMG segments.
Close · 3M
+4.16%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
AIVL · Weight decrease · 2d
weight 0.915% → 0.904% (-0.011 pp)·stock up 2.5% in the 30 days before
Oct 20·entry $247.36·now $240.03
AIVL · Weight decrease · 2d
weight 0.927% → 0.915% (-0.012 pp)·stock up 7.0% in the 30 days before
Oct 15·entry $248.52·now $240.03
AIVL · Weight increase · 2d
weight 0.923% → 0.927% (+0.004 pp)·stock up 7.2% in the 30 days before
Oct 13·entry $250.48·now $240.03Fresh
AIVL · Weight decrease · 3d
weight 0.951% → 0.923% (-0.028 pp)·stock up 6.1% in the 30 days before
Oct 9·entry $248.58·now $240.03
AIVL · Weight decrease · 2d
weight 0.951% → 0.927% (-0.024 pp)·stock up 4.8% in the 30 days before
Oct 8·entry $247.52·now $240.03
AIVL · Accumulation · 5d
weight 0.923% → 0.953% (+0.030 pp)·stock up 8.0% in the 30 days before
Oct 2·entry $251.93·now $240.03Fresh
AIVL · Accumulation · 5d
weight 0.916% → 0.947% (+0.031 pp)·stock up 7.7% in the 30 days before
Oct 1·entry $249.09·now $240.03Fresh
AIVL · Accumulation · 5d
weight 0.899% → 0.944% (+0.046 pp)·stock up 5.3% in the 30 days before
Sep 30·entry $247.73·now $240.03Fresh
AIVL · Accumulation · 6d
weight 0.889% → 0.952% (+0.063 pp)·stock up 6.2% in the 30 days before
Sep 29·entry $250.78·now $240.03Fresh
AIVL · Accumulation · 7d
weight 0.874% → 0.954% (+0.080 pp)·stock up 3.3% in the 30 days before
Sep 28·entry $251.67·now $240.03Fresh
AIVL · Accumulation · 7d
weight 0.870% → 0.945% (+0.075 pp)·stock up 2.3% in the 30 days before
Sep 25·entry $250.74·now $240.03Fresh
AIVL · Accumulation · 6d
weight 0.873% → 0.933% (+0.060 pp)·stock up 2.5% in the 30 days before
Sep 24·entry $247.74·now $240.03Fresh
AIVL · Accumulation · 6d
weight 0.867% → 0.923% (+0.056 pp)·stock up 1.7% in the 30 days before
Sep 23·entry $246.45·now $240.03Fresh
AIVL · Accumulation · 5d
weight 0.896% → 0.916% (+0.021 pp)·stock up 2.4% in the 30 days before
Sep 22·entry $245.41·now $240.03Fresh
AIVL · Accumulation · 5d
weight 0.872% → 0.899% (+0.026 pp)·stock up 0.9% in the 30 days before
Sep 21·entry $241.23·now $240.03Fresh
AIVL · Weight increase · 2d
weight 0.870% → 0.889% (+0.019 pp)·stock down 2.3% in the 30 days before
Sep 18·entry $237.64·now $240.03Fresh
AIVL · Accumulation · 5d
weight 0.850% → 0.873% (+0.023 pp)·stock down 8.0% in the 30 days before
Sep 15·entry $234.45·now $240.03Drifting
AIVL · Accumulation · 5d
weight 0.854% → 0.896% (+0.043 pp)·stock down 6.4% in the 30 days before
Sep 11·entry $241.87·now $240.03Fresh
AIVL · Weight increase · 3d
weight 0.850% → 0.876% (+0.026 pp)·stock down 6.6% in the 30 days before
Sep 9·entry $236.27·now $240.03Fresh
AIVL · Weight increase · 2d
stock down 6.3% in the 30 days before
Sep 8·entry $237.76·now $240.03Fresh
PQUS · Exit · 1d
weight 0.050% → 0 (exited)·stock up 7.7% in the 30 days before
Oct 1·entry $249.09·now $240.03
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
AI ETFs, specifically AIVL, have been gradually accumulating AMETEK shares over recent days, indicating a positive outlook on the company. This stands in direct contrast to the framework's 'Fail' verdict, which highlights concerns regarding the lack of sufficient financial data to affirm health and the seemingly stretched valuation.
- Circle of CompetenceThe company's focus on specialized electrical components and instrumentation for diverse industrial applications suggests predictable unit economics for long-term cash flow projection.
- Economic MoatAMETEK likely benefits from switching costs and specialized engineering expertise, providing a durable competitive advantage in its niche industrial segments.
- ManagementThere is insufficient information provided to assess management's candor, capital allocation discipline, or alignment of interests with shareholders.
- Financial HealthThe provided single-year ROE is below the 15% target average, and there is insufficient data on 10-year ROE, operating margins, debt, or owner earnings to confirm financial health criteria.
- Margin of SafetyCurrent valuation multiples (PER 36.64, EV/EBITDA 32.49) appear high, suggesting no evident margin of safety or even a demonstrably fair price relative to available financial performance data.
AMETEK appears to operate within a predictable industry and may possess a durable economic moat; however, the analysis is hampered by insufficient financial data to fully assess long-term health. Critically, the current high valuation multiples suggest an absence of a margin of safety, leading to an overall 'Fail' verdict within this framework.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.